TXNIP and type 1 diabetes mellitus: Combination therapy of GABA with a complimentary oral agents such as a TxNIP inhibitor or positive allosteric modifier in stage 2 T1D is an inexpensive intervention, and especially attractive insofar as the low toxicity.